The weekly litigation news digest is live. Subscribe now

IP Verse

Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als - EP1714960

The patent EP1714960 was granted to Mitsubishi Pharma on Mar 28, 2018. The application was originally filed on Feb 9, 2005 under application number EP05709984A. The patent is currently recorded with a legal status of "Revoked".

EP1714960

MITSUBISHI PHARMA
Application Number
EP05709984A
Filing Date
Feb 9, 2005
Status
Revoked
Aug 21, 2020
Publication Date
Mar 28, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDDec 20, 2018- -

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTJP2003081830
INTERNATIONAL-SEARCH-REPORTJP2003083977
INTERNATIONAL-SEARCH-REPORTWO0234264
OPPOSITIONEP1405637
SEARCHEP1405637
SEARCHWO0234264

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents